Genmab A/S
HUMANIZED OR CHIMERIC CD3 ANTIBODIES
Last updated:
Abstract:
The present invention relates to humanized or chimeric antibodies binding CD3. It furthermore relates to bispecific antibodies, compositions, pharmaceutical compositions, use of said antibodies in the treatment of a disease, and method of treatment.
Status:
Application
Type:
Utility
Filling date:
14 Jul 2016
Issue date:
19 Sep 2019